JP2024527940A5 - - Google Patents
Info
- Publication number
- JP2024527940A5 JP2024527940A5 JP2024504834A JP2024504834A JP2024527940A5 JP 2024527940 A5 JP2024527940 A5 JP 2024527940A5 JP 2024504834 A JP2024504834 A JP 2024504834A JP 2024504834 A JP2024504834 A JP 2024504834A JP 2024527940 A5 JP2024527940 A5 JP 2024527940A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- process according
- glycero
- membered heteroaryl
- membered heterocycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163225822P | 2021-07-26 | 2021-07-26 | |
| US63/225,822 | 2021-07-26 | ||
| PCT/US2022/038152 WO2023009422A1 (en) | 2021-07-26 | 2022-07-25 | Processes for preparing lipid nanoparticle compositions for the delivery of payload molecules to airway epithelium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024527940A JP2024527940A (ja) | 2024-07-26 |
| JP2024527940A5 true JP2024527940A5 (cg-RX-API-DMAC7.html) | 2025-08-04 |
Family
ID=82899171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024504834A Pending JP2024527940A (ja) | 2021-07-26 | 2022-07-25 | ペイロード分子を気道上皮に送達するための脂質ナノ粒子組成物を調製するプロセス |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240366522A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4376815A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024527940A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118019526A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202320737A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023009422A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020002348A (es) | 2017-08-31 | 2020-10-08 | Modernatx Inc | Métodos de elaboración de nanopartículas lipídicas. |
| CN113939282A (zh) | 2019-01-31 | 2022-01-14 | 摩登纳特斯有限公司 | 制备脂质纳米颗粒的方法 |
| CZ310613B6 (cs) | 2020-09-23 | 2026-01-28 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Lipidoidy pro transfekci nukleových kyselin a jejich použití |
| CZ310443B6 (cs) | 2021-07-19 | 2025-06-25 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití |
| EP4429644A1 (en) * | 2021-11-12 | 2024-09-18 | ModernaTX, Inc. | Compositions for the delivery of payload molecules to airway epithelium |
| EP4694871A1 (en) * | 2023-04-14 | 2026-02-18 | Beijing Jitai Pharmaceutical Technology Co., Ltd. | Lipid nanoparticle compositions and uses thereof |
| AU2024384477A1 (en) | 2023-11-21 | 2026-05-21 | Modernatx, Inc. | Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis |
| CN120718086B (zh) * | 2024-06-13 | 2026-06-26 | 仁景(苏州)生物科技有限公司 | 用于递送的脂质化合物和脂质纳米颗粒 |
| WO2026128816A1 (en) * | 2024-12-13 | 2026-06-18 | Massachusetts Institute Of Technology | Compositions and methods for stabilizing biomolecules |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5681702A (en) | 1994-08-30 | 1997-10-28 | Chiron Corporation | Reduction of nonspecific hybridization by using novel base-pairing schemes |
| EP2857499A1 (en) | 2010-10-01 | 2015-04-08 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| US9999673B2 (en) | 2011-01-11 | 2018-06-19 | Alnylam Pharmaceuticals, Inc. | PEGylated lipids and their use for drug delivery |
| WO2013103659A1 (en) | 2012-01-04 | 2013-07-11 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Stabilizing rna by incorporating chain-terminating nucleosides at the 3'-terminus |
| WO2014093924A1 (en) | 2012-12-13 | 2014-06-19 | Moderna Therapeutics, Inc. | Modified nucleic acid molecules and uses thereof |
| PT2922554T (pt) | 2012-11-26 | 2022-06-28 | Modernatx Inc | Arn modificado nas porções terminais |
| WO2014164253A1 (en) | 2013-03-09 | 2014-10-09 | Moderna Therapeutics, Inc. | Heterologous untranslated regions for mrna |
| US20160024181A1 (en) | 2013-03-13 | 2016-01-28 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| CN105143456A (zh) | 2013-03-15 | 2015-12-09 | 不列颠哥伦比亚大学 | 用于转染的脂质纳米粒子和相关方法 |
| DK3386484T3 (da) | 2015-12-10 | 2022-07-04 | Modernatx Inc | Sammensætninger og fremgangsmåder til afgivelse af terapeutiske midler |
| US20180153822A1 (en) * | 2016-11-10 | 2018-06-07 | Translate Bio, Inc. | Process of Preparing mRNA-Loaded Lipid Nanoparticles |
| JP7256824B2 (ja) * | 2018-04-25 | 2023-04-12 | エスリス ゲーエムベーハー | 粒子状製剤用の凍結保護剤 |
| US12076439B2 (en) * | 2018-05-24 | 2024-09-03 | Translate Bio, Inc. | Thioester cationic lipids |
| CN113939282A (zh) * | 2019-01-31 | 2022-01-14 | 摩登纳特斯有限公司 | 制备脂质纳米颗粒的方法 |
| CA3146369A1 (en) * | 2019-07-08 | 2021-01-14 | Translate Bio, Inc. | Improved mrna-loaded lipid nanoparticles and processes of making the same |
-
2022
- 2022-07-25 WO PCT/US2022/038152 patent/WO2023009422A1/en not_active Ceased
- 2022-07-25 EP EP22754669.4A patent/EP4376815A1/en active Pending
- 2022-07-25 CN CN202280065046.4A patent/CN118019526A/zh active Pending
- 2022-07-25 US US18/291,710 patent/US20240366522A1/en active Pending
- 2022-07-25 JP JP2024504834A patent/JP2024527940A/ja active Pending
- 2022-07-25 TW TW111127850A patent/TW202320737A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024527939A5 (cg-RX-API-DMAC7.html) | ||
| JP2023538260A5 (cg-RX-API-DMAC7.html) | ||
| CN118319880B (zh) | 靶向肺部高效递送核酸的脂质纳米颗粒、吸入式制剂及应用 | |
| JP2025502627A5 (cg-RX-API-DMAC7.html) | ||
| US20130037977A1 (en) | Preparation of Lipid Nanoparticles | |
| JP2024542099A5 (cg-RX-API-DMAC7.html) | ||
| JP2020510072A5 (cg-RX-API-DMAC7.html) | ||
| CN119317431A (zh) | 使用阳离子胆固醇用于核酸递送的局部递送的脂质纳米颗粒 | |
| JP2018532721A5 (cg-RX-API-DMAC7.html) | ||
| JP2024545584A5 (cg-RX-API-DMAC7.html) | ||
| RU2660585C2 (ru) | Фармацевтическая композиция для уменьшения осложнений применения стероидных препаратов при лечении офтальмологических заболеваний | |
| TW200916126A (en) | Organic compounds | |
| CN115708818B (zh) | 一种用于雾化吸入脂质纳米粒的通用型处方 | |
| EP4079298A1 (en) | Kit for preparing nanoparticle composition for drug delivery, comprising polylactic acid salt | |
| WO2024046448A1 (en) | Lyophilized formulations and liquid formulations of lipid nanoparticles | |
| US8871252B2 (en) | pH-responsive liposome | |
| JP6230538B2 (ja) | 安定なオキサリプラチン封入リポソーム水分散液及びその安定化方法 | |
| JP7832717B2 (ja) | 硫化物を含むイオン化可能な脂質、及びこれを含む脂質ナノ粒子 | |
| US20230355539A1 (en) | Lipid-polymer compositions and methods of use | |
| CN117946201A (zh) | 脂质化合物和脂质纳米颗粒组合物 | |
| US8241663B2 (en) | Liposome preparation | |
| WO2023183297A1 (en) | Ion channel prosthetic compositions comprising lipid-coated crystals of amphotericin b | |
| KR102772764B1 (ko) | 트레할로즈 유도체 및 신규 구조 유지 화합물을 포함하는 핵산 의약품 전달용 지질나노입자의 약학 조성물 | |
| WO2025012723A1 (en) | Liposome encapsulated apomorphine | |
| CN106619509B (zh) | 一种奥沙利铂和伊立替康共载载药脂肪乳及其制备方法 |